“The industry has gotten really, really good at commercializing a molecule once you know it's right, but has increasingly gotten worse at finding the right molecule. We're letting AI lead the way for answers that already exist in nature.”

Wall Street Journal (via Quartz) · Sep 22 · Enveda raises $311M at $2B valuation to advance AI-discovered drugs